Targeting Prion-like Cis Phosphorylated Tau Pathology in Neurodegenerative Diseases.

J Alzheimers Dis Parkinsonism
Authors
Abstract

Tau is a microtubule-associated protein heavily implicated in neurodegenerative diseases collectively known as tauopathies, including Alzheimer's disease and chronic traumatic encephalopathy. Phosphorylation of tau at Thr231 allows for the isomerization of phosphorylated tau (p-tau) into distinct cis and trans conformations. Cis, but not trans, p-tau is detectable not only in Alzheimer's disease and chronic traumatic encephalopathy, but also right after traumatic brain injury depending on injury severity and frequency both in humans and animal models. Cis p-tau is not only neurotoxic but also spreads from a neuron to another in a prion-like fashion, functioning as a primary driver of neurodegeneration, which can be effectively neutralized by cis p-tau antibody. This represents an exciting new opportunity for understanding disease development and developing early biomarkers and effective therapies of tauopathies.

Year of Publication
2018
Journal
J Alzheimers Dis Parkinsonism
Volume
8
Issue
3
Date Published
2018
ISSN
2161-0460
DOI
10.4172/2161-0460.1000443
PubMed ID
30197831
PubMed Central ID
PMC6122852
Links
Grant list
R01 AG029385 / AG / NIA NIH HHS / United States
R01 AG046319 / AG / NIA NIH HHS / United States
R01 CA167677 / CA / NCI NIH HHS / United States